Gil Barzilay

Dr. Barzilay has a Diploma in Chinese Medicine (Dipl. CM, I.A.TCM) with distinction from Broshim College of Integrative Medicine, Tel Aviv University, where he studied both Acupuncture and Chinese Herbal Medicine. In addition, he has completed a 1-year specialty course in "Chinese & Macrobiotics Nutrition (TEF Method)" with Eyal Shpringer.
Dr. Barzilay works in his clinic in central Tel Aviv and in "Refuot", one of the leading CAM Clinics in Israel. He also teaches "Chinese Medicine Research" for 3rd and 4th Year students in Broshim College where he also supervises the students' final year Research Projects. In addition, he is an assistant in the "Acupuncture Techniques" course for 2nd year students.
Dr. Barzilay is also part of the International Community of Chinese Medicine (ICCM) Organization Core Team and leads ICCM's Marketing & International Relations, as well as being in charge of the ICCM Science & Research Day. He writes regularly research reviews & newsletters for Broshim, ICCM and other organizations (Facebook: drgiltcm).
Before studying Chinese Medicine, Dr. Barzilay worked in Teva Pharmaceuticals, leading Global Marketing for the Innovative Multiple Sclerosis business (Copaxone©) with sales over $4 Billion.
Dr. Barzilay has a B.Sc (Honors) from Imperial College, University of London, a Ph.D from Oxford University in Cancer Research and a European Medical Biology Organization (EMBO) Post-Doctoral fellowship at the Weizmann Institute, specializing in Cell Death (Apoptosis) research.